Home / Tocilizumab / Czechia
CZ ATC L04AC07 · updated 2 Nov 2026
Tocilizumab shortage in Czechia
Is there a Tocilizumab shortage in Czechia?
Yes. As of 2 Nov 2026, 1 Tocilizumab product is reported short in Czechia, the first since 13 Aug 2026. The company estimate for the return is 31 Dec 2026. Main reason: distribution or logistics.
Also short in Canada, Italy, Austria, Japan. All countries.
Affected products in Czechia
| Country | Product | Company | Since | Expected back | Reason |
|---|---|---|---|---|---|
| CZ | TYENNE 162MG 162MG INJ SOL ISP 4X0,9ML | Fresenius Kabi Deutschland GmbH, Bad Homburg | 13 Aug 2026 | 31 Dec 2026 | Distribution or logistics Kapacitní/distribuční důvody |
Source
SÚKL (State Institute for Drug Control), market reports. Official list. Products whose latest market report is a supply interruption; one row per SÚKL code.